• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Reinforcing Omega-3 Supply Networks

    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Eriomin Associated with Improved Microbiota in People with Prediabetes

    BAPP Publishes Lab Guidance Document on Lavender Oil

    Bartek Provides Update on Construction of World's Largest Malic, Fumaric Acid Facility

    Contract Manufacturer Acquires Powder Processing Facility

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Exclusives
    Top Companies
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ThymoQuin Black Seed Oil Linked to Oral Health Benefits

    DolCas to Showcase Research on Ginger Extract and PMS Symptoms

    Eriomin Associated with Improved Microbiota in People with Prediabetes

    4: Jamieson Wellness

    5: Carlson Labs
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    ThymoQuin Black Seed Oil Linked to Oral Health Benefits

    DolCas to Showcase Research on Ginger Extract and PMS Symptoms

    Eriomin Associated with Improved Microbiota in People with Prediabetes

    Top Dietary Supplement Companies and Brands

    5: Carlson Labs
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    ThymoQuin Black Seed Oil Linked to Oral Health Benefits

    DolCas to Showcase Research on Ginger Extract and PMS Symptoms

    Eriomin Associated with Improved Microbiota in People with Prediabetes

    Probi to Debut Cognitive Support Concept

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    CoQ10 Association

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)

    Trust Transparency Consulting
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    CoQ10 Association

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)

    Trust Transparency Consulting
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Top Companies
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Emerging Regulatory Pathways for Nutraceuticals

    Each product class offers unique options for making claims and communicating benefits to consumers and healthcare professionals.

    Emerging Regulatory Pathways for Nutraceuticals
    By Gregory Stephens, Windrose Partners & Sanford Bigelow, PhD, DABT, Vanguard Global Associates LLC04.01.19
    In this column, Windrose Partners LLC and Vanguard Global Associates LLC provide an overview of regulatory considerations for taking new products to market. More specifically, our goal herein is to provide product formulators and marketing personnel with a brief roadmap toward development of commercially viable products while achieving regulatory acceptance in
    the marketplace.  
     
    Historically, the regulatory pathway to market for “nutraceutical” products has a been either as dietary supplements or fortification of conventional foods. To varying degrees this served the market well with the exception of nutritional products that offer disease management benefits. Both dietary supplements and conventional foods can make approved health claims and qualified health claims, but these are somewhat limiting and require a rigorous, often costly and time-consuming regulatory process within the FDA. A simpler way to make product claims is to use structure-function claims, which do not require FDA approval.
     
    Additional regulatory pathways that have been less frequently utilized include Medical Foods and Foods for Special Dietary Use. Each afford their own unique regulatory requirements and allowed claims; however, neither requires FDA premarket approval. Still, some companies have chosen one of these routes without understanding the FDA requirements and statutory guidelines.
     
    Regulatory Pathways for Nutritional Products
    Is your product conventional food, a food for special dietary use, a dietary supplement, or perhaps a medical food? It depends largely on the composition and intended use. FCC (2019) lists identity and purity standards for many food and supplement ingredients. The following overview of the U.S. regulatory requirements for such products provides context in assessing composition and directions for use, product and ingredient safety, claims, regulatory status of the ingredients, and the intended use of the product.  
     
    The general categories of food products regulated by the FDA include: conventional food, dietary supplements, foods for special dietary use (e.g., foods intended for weight loss), and medical foods, as well as infant formulas. (From a regulatory perspective, the terms “functional foods” and “nutraceuticals” are marketing terms and are not classified as a regulatory category of food products.)  
     
    Conventional Foods. Many conventional foods that are common staples of the U.S. diet have food standards that establish minimum ingredient and nutrient content originally intended to support nutrient adequacy and reduce the likelihood of economic deception to consumers. These standards are codified under 21 Code of Federal Regulations (CFR) Parts 130-169. 
     
    Dietary Supplements. The Dietary Supplement Health and Education Act (DSHEA) of 1994 defined dietary supplements as articles or products intended to supplement the diet that bear or contain one or more specific ingredient. Dietary supplements can be viewed from a regulatory perspective as a subcategory of food. They are further defined as products not represented as a conventional food or as a sole item of a meal or the diet.  
     
    Dietary supplement products contain ingredients (i.e., dietary ingredients) which are divided into two categories: 1) new dietary ingredients (NDIs) and old dietary ingredients (ODIs). NDIs are supplement ingredients whose use occurred after Oct. 25, 1994, whereas ODIs were used before this date. Dietary supplement products are acceptable in the following forms:  tablet, capsule, softgel, gelcap, or as a liquid (21 U.S.C. § 411(c)). Currently, as a point of differentiating foods from supplements and as currently practiced, a 2 fl. oz. shot is viewed as a supplement product whereas an 8 fl. oz. beverage is viewed as a conventional food.  
     
    Foods for Special Dietary Use. This category is drawing considerable interest from food and supplement marketers hoping to make more compelling product claims. Foods for special dietary use are defined as articles or products 1) used for supplying particular dietary needs which exist by reason of a physical, physiological, pathological or other condition, including but not limited to the conditions of diseases, convalescence, pregnancy, lactation, allergic hypersensitivity to food, underweight, and overweight; 2) used for supplying particular dietary needs which exist by reason of age, including but not limited to infancy and childhood; 3) used for supplementing or fortifying the ordinary or usual diet with any vitamin, mineral, or other dietary property, and are intended for persons who otherwise can consume a normal diet containing a normal range of nutrient intakes to meet their physiological needs.  
     
    Foods for special dietary use can be viewed as a regulatory antecedent to medical foods (as the first regulations for foods for special dietary use were promulgated in 1941), yet foods for special dietary use do not require use under the care of a healthcare practitioner. The intended use of foods for special dietary purposes includes intake for persons with allergies (i.e., the food is presented as hypo-allergenic) and for weight loss and maintenance. Both of these uses have been codified (21 CFR 105). Foods for special dietary use are generally intended for healthy people who otherwise have special dietary needs (e.g., Lactaid milk for people with lactose intolerance) as compared to medical foods, which are used for the dietary management of a disease or other health conditions. 
     
    Medical Foods. Medical foods are formulated to be consumed or administered enterally under the supervision of a physician or healthcare practitioner, and are intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements—based on recognized scientific principles—are established by medical evaluation (21 U.S.C. § 360ee (b) (3)). Medical foods are the only regulatory category of food products that are intended for use by patients who are under the care of a healthcare practitioner.  
     
    Their intended use is for patients with a disease that has a distinctive nutritional requirement (a pathophysiological condition that requires dietary intake of specific nutrients that exceed the normal range associated with a normal diet); and their use is under the terms of specific dietary management of the disease. Distinctive nutritional requirements are an integral part of how medical foods are defined, as it is important to determine which diseases medical foods are suitable for. The FDA has yet to define distinctive nutritional requirements, yet the agency provided multiple interpretations in its 1996 ANPR.  
     
    Typical medical foods are enteral nutrition products (i.e., products provided through the gastrointestinal tract, taken by mouth, or provided through a nasogastric tube or catheter that delivers nutrients beyond the oral cavity or directly to the stomach). 
     
    In the preamble to the proposed rule to exempt medical foods from requirements under the Nutrition Labeling and Education Act (NLEA), the FDA (1991) recognized that some medical foods are available in the retail setting by stating “they are generally not available on the retail shelf.” FDA (1991, 2008a, 2011, 2013) recognized that medical foods are used by “patients receiving active and ongoing medical supervision (e.g., in a healthcare facility or as an outpatient) [emphasis added].” Medical foods are exempt from NLEA labeling requirements (FDA 1993) under 21 CFR 101.9(j)(8). 
     
    Key Regulatory Considerations 
    Safety. In addition to regulation of product claims, safety standards are critical. All food ingredients must be 1) approved by the FDA as a food additive or color additive, 2) be prior sanctioned by the FDA, or 3) be Generally Recognized As Safe (GRAS) either by the FDA or self-determined by a panel of experts qualified by training and experience (21 CFR 170). FDA has offered guidence on safety tests for determining product and ingredient safety (2007).
     
    Types of Labeling Claims. The Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 343), amended by the NLEA and DHSEA, allows for companies to make the following health-related claims in product labeling: 1) structure/function claims (FDA 2000, 2003b, 2008a, 2010); 2) health claims (e.g., soy protein and blood cholesterol— FDA 1998, 1999); 3) medical food claims; and 4) nutrient content claims.  
     
    Substantiating Product Claims. The U.S. Federal Trade Commission (FTC) and FDA work together to regulate the food, medical food, and supplement industry. For such products, the FTC regulates advertising and the FDA regulates labeling. Advertising is viewed as product representations made beyond those listed on labeling. In general, the overriding principle for substantiating claims is that the quantity and quality of the scientific evidence must match the nature and specificity of the claim.  
     
    Details on permissible product claims, their substantiation, and product safety requirements are beyond the scope of this article and will be addressed in more detail in the future.
     
    Conclusions
    The regulatory pathway to market for a nutraceutical product is not simple and it may entail significant risk. There are emerging options that product developers (i.e., formulators and marketing personnel) can take; each offers options to make compelling claims, communicating product benefits to consumers/patients and healthcare professionals. We strongly suggest marketers who are considering different regulatory pathways consult with qualified experts to minimize risks and help achieve commercial success.



    Gregory Stephens
    Windrose Partners
     
    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 267-432-2696; E-mail: gregstephens@windrosepartners.com.

    Sandy Bigelow
    Vanguard Global Associates
    Sandy Bigelow, PhD, DABT, is principal at Vanguard Global Associates LLC (VGA), a leading-edge consultancy of experienced associates who work together to develop creative solutions to their clients’ challenges. VGA helps clients deal with the safety and claims aspects of commercializing their ingredients and products. Bigelow is Board Certified in General Toxicology (DABT), qualifying a practice in safety assurance and evaluation. 

     

    References
    Code of Federal Regulations, U.S. Government Printing Office, Washington, D.C., 20001. 
    FCC. 2019. Food Chemical Codex monographs. Online, and Ninth Edition, and Accompanying Supplements. U.S. Pharmacopeial Convention. Rockville, MD  20852.  
    FDA 1991. U.S. Food and Drug Administration. Nutrition Labeling and Education Act. Proposed Rule. 56 Federal Register 60366 (November 27, 1991).  
    FDA 1993. Nutrition Labeling and Education Act. Final Rule. 58 Federal Register 2079 (January 6, 1993).  
    FDA 1996. Regulation of Medical Foods. Advance Notice of Proposed Rulemaking. 21 Federal Register 60661 (November 29, 1996).  
    FDA 1998. Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease. Proposed Rule. Federal Register 63:62977. November 10, 1998.  
    FDA 1999. Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease. Final Rule.    21 Federal Register 57,700 (October 26, 1999).  
    FDA 2000. Regulations on Statements Made for Dietary Supplements Concerning the Effect of the Product on the Structure or Function of the Body. Final Rule. 65 Federal Register 1000, January 6, 2000.  
    FDA 2003. Claims That Can Be Made for Conventional Foods and Dietary Supplements.  Guidance for Industry.  Found at:  http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ucm111447.htm.  
    FDA 2007. U.S. Food and Drug Administration. FDA Redbook. Guidance for Industry and Other Stakeholders. Toxicological Principles for the Safety Assessment of Food Ingredients.  http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/default.htm.  
    FDA 2008a. Medical Foods – Domestic and Import. FDA Compliance Program Guidance Manual.  7321.002. Completion date: September 30, 2008. pp. 30.  
    FDA 2008b. Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act. Guidance for Industry. Found at: (http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/DietarySupplements/ucm073200.htm).  
    FDA 2010. Structure/Function Claims for Dietary Supplements and Conventional Foods.  Guidance for Industry. Found at:  http://www.fda.gov/Food/LabelingNutrition/LabelClaims/StructureFunctionClaims/default.htm
    FDA 2011. Guidance for Industry: Frequently Asked Questions About Medical Foods. May 1997, updated May 2007 and July 2011. Accessed May 2013 at:  http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/MedicalFoods/ucm054048.htm.  
    FDA 2013. Draft Guidance for Industry: Frequently Asked Questions About Medical Foods; Second Edition, revised May 1997, revised May 2007, revised August 2013, pp.13.  
    FDA 2014. Food Allergens. http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAllergens/default.htm, accessed March 28, 2016.  
    FDA 2016a. Substances Generally Recognized As Safe. Final Rule. U.S. Food and Drug Administration. Federal Register 81:54,960. August 16, 2016.  
    FDA 2016b. Dietary Supplements: New Dietary Ingredient Notifications and Related Issues:  Draft Guidance for Industry. August 2016, pp. 102.  
    FDA 2017a. Regulatory Framework for Substances Intended for Use in Human Food or Animal Food on the Basis of the Generally Recognized As Safe (GRAS) Provision of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. U.S. Food and Drug Administration. November 2017, pp. 28.
    FDA 2017b. Best Practices for Convening a GRAS Panel: Guidance for Industry. Draft Guidance.  U.S. Food and Drug Administration. November 2017, pp. 30.    
    Federal Register, U.S. Government Printing Office, Washington, D.C., 20001.  
    FTC 1994. Enforcement Policy Statement on Food Advertising, May 1994. Federal Trade Commission, Washington, DC.; 59 Federal Register 28388; June 1, 1994.  
    FTC 1998. Dietary Supplements: An Advertising Guide for Industry, Bureau of Consumer Protection, Federal Trade Commission, 26 pp.  
    FTC 2001. Dietary Supplements: An Advertising Guide for Industry, Bureau of Consumer Protection, Federal Trade Commission, pp. 32.  
    Suggs-Anderson, S. 2011. Regulation of Medical Foods. Shawne Suggs-Anderson, MMSc, RD.  Infant Formula and Medical Foods Staff. ONLDS/CFSAN/FDA. NORD Medical Foods Conference.  February 10, 2011. PowerPoint slide deck, pp. 22. 
     
    Related Searches
    • Regulations
    • Nutrients
    • Health
    • ftc
    Related Knowledge Center
    • Medical Nutrition
    • Regulations
    • Dietary Supplements
    Suggested For You
    Nutrition Innovation Nutrition Innovation
    Windrose Partners LLC Windrose Partners LLC
    MGP Ingredients Receives FDA Approval of Fibersym RW and FiberRite RW as a Dietary Fiber Source MGP Ingredients Receives FDA Approval of Fibersym RW and FiberRite RW as a Dietary Fiber Source
    FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease
    FDA Plans to Modernize Dietary Supplement Regulations FDA Plans to Modernize Dietary Supplement Regulations
    Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model
    CRN Unveils New Chairman, 2019 Board of Directors CRN Unveils New Chairman, 2019 Board of Directors
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    Nuances of the Healthcare Institutional Nutrition Market Nuances of the Healthcare Institutional Nutrition Market
    Fiber Revisited: Closing the Gap Fiber Revisited: Closing the Gap
    Nutritional Supplements Access Preserved in Arizona Nutritional Supplements Access Preserved in Arizona
    FDA Launches Dietary Supplement Working Group FDA Launches Dietary Supplement Working Group
    Examining Testing & Certification for Dietary Supplements Examining Testing & Certification for Dietary Supplements
    BrandHive’s Jeff Hilton to Present on Blurring Lines of Supplements, Foods & Pharma BrandHive’s Jeff Hilton to Present on Blurring Lines of Supplements, Foods & Pharma
    ‘No Pain, No Gain?’ What’s the Real Story? ‘No Pain, No Gain?’ What’s the Real Story?

    Related Buyers Guide Companies

    • Nutrition Innovation

      ...
      ALAN ROBERTS, Owner & Formulator 09.26.23

    • Windrose Partners LLC

      ...
      Greg Stephens, President & Managing Partner 10.06.22

    • Breaking News | Fiber & Carbohydrates | Functional Foods & Beverages | Regulations | Supplier News

      MGP Ingredients Receives FDA Approval of Fibersym RW and FiberRite RW as a Dietary Fiber Source

      New FDA verification allows MGP to continue to provide dietary fiber benefits on food labels.
      03.29.19


    • Breaking News | Dietary Supplements | Quality & Safety | Regulations | Regulatory News
      FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease

      FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease

      Failure to correct violations may result in legal action, including product seizure and/or injunction.
      02.12.19

    • Dietary Supplements | Quality & Safety | Regulations
      FDA Plans to Modernize Dietary Supplement Regulations

      FDA Plans to Modernize Dietary Supplement Regulations

      Agency seeks to balance consumer access to safe, lawful products while promoting industry innovation.
      By Sean Moloughney, Editor 02.12.19

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    • New Technology Converts Sugar In Juice To Fiber
    • HMB And Vitamin D Supplementation Linked To Reduction In Fat Stores
    Breaking News
    • Eriomin Associated with Improved Microbiota in People with Prediabetes
    • BAPP Publishes Lab Guidance Document on Lavender Oil
    • Bartek Provides Update on Construction of World's Largest Malic, Fumaric Acid Facility
    • Contract Manufacturer Acquires Powder Processing Facility
    • D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Eriomin Associated with Improved Microbiota in People with Prediabetes
    BAPP Publishes Lab Guidance Document on Lavender Oil
    Bartek Provides Update on Construction of World's Largest Malic, Fumaric Acid Facility
    Coatings World

    Latest Breaking News From Coatings World

    Dunn-Edwards Names ‘Skipping Stones’ 2024 Color of the Year
    PPG Partners with Prague Crafts Academy to Train Next Generation of Painters
    RPM Acquires Leading Panelized Wall Systems Business
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study: Truvian's Benchtop Blood Testing Results are Consistent With Central Lab Analyzers
    Insulet CFO Leaves for Same Role at 3M Health Care Spinoff
    Phillips-Medisize, GlucoModicum Team Up on Needle-Free CGM
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Emmes Appoints Matt Bond CFO
    PTC Furthers Workforce Reduction
    PharmaEssentia, WuXi Biologics Ink Exclusive Global License Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ho.Bag Corporate Acquires SR Packaging Consultants
    Aurelius Group Joins Bid for The Body Shop
    Thrive Causemetics Launches ‘Sheryl’ Lipstick to Honor Find Your Fabulosity Founder
    Happi

    Latest Breaking News From Happi

    IFRA Promotes Revised Classification, Labeling and Packaging of Chemical Substances and Mixtures
    Wellness Brand Agent Nateur's Launch With Vitamin Shoppe Takes Manhattan
    In-Cosmetics Asia To Spotlight Key Developments in APAC Cosmetics Market
    Ink World

    Latest Breaking News From Ink World

    MUTOH Releases ValueJet 628MP Multi-Purpose Printer
    Inkcups to Showcase Portfolio at PRINTING United 2023
    Koenig & Bauer Factory in Radebeul Celebrates Its Jubilee
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    All Printing Resources partners with MicroDynamics
    IST America to make Printing United debut
    Sun Chemical’s Glenn Webster receives NAPIM award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ahlstrom Launches Glass Fiber Tissue Line
    Conwed Refreshes Branding, Website
    Registration Opens for 2024 ACI Convention
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Relievant's Intracept Procedure Granted Anthem Blue Cross and Blue Shield Coverage
    Study: Brain Exercise Helps with Knee Surgery Recovery
    Loci Ortho Completes Enrollment for THANKS Clinical Trial
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    ASSA ABLOY Acquires Inovadoor in Brazil
    Walmart CEO Doug McMillon to Keynote CES 2024
    JDI Launches Launch Large-Scale eLEAP Project in China

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login